Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)
Clinical trial NCT04003103 · COMPLETED
Trial details
- NCT number
- NCT04003103
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-19
- Primary completion
- 2022-03-18
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.